Quest Diagnostics Inc. closed 8.75% short of its 52-week high of $182.38, which the company achieved on June 16th.

This was the stock's second consecutive day of losses.

Quest Diagnostics (DGX) is a strong buy with growth potential, solid margins, and dividend increases. Discover the full ...

IF YOU KNOW you’ve been exposed to something potentially toxic, seek emergency medical care. Some signs that this may have ...

Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts. On June ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced the launch of a new diagnostic laboratory test for the Oropouche virus, an emerging disease that is ...

The Durham-based parent company says it still plans to grow Q2 Solutions’ local headcount despite the grant terminations.

Substance use occurs more often in blue-collar and service industry jobs, but comprehensive policies and supportive ...

Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. | The Lumipulse G blood test measures the ratio between ...

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...

Before the New York Giants reach training camp, Jaxson Dart was on vacation and showing off his arm strength in a new viral ...

New York Giants rookies officially report for training camp on Tuesday, one week ahead of the remainder of the team.